UbcH10 expression on thyroid fine-needle aspirates. (Q54424494)

29 May 2018

title

UbcH10 expression on thyroid fine-needle aspirates. (English)

1 reference

29 May 2018

author

Angelo Ferraro

2

1 reference

29 May 2018

Alfredo Fusco

9

1 reference

29 May 2018

author name string

Eliana Guerriero

1

1 reference

29 May 2018

Doriana Desiderio

3

1 reference

29 May 2018

Pierlorenzo Pallante

4

1 reference

29 May 2018

Maria Teresa Berlingieri

5

1 reference

29 May 2018

Antonino Iaccarino

6

1 reference

29 May 2018

Emiliano Palmieri

7

1 reference

29 May 2018

Lucio Palombini

8

1 reference

29 May 2018

Giancarlo Troncone

10

1 reference

29 May 2018

publication date

1 June 2010

1 reference

29 May 2018

published in

Cancer Cytopathology

1 reference

29 May 2018

volume

118

1 reference

29 May 2018

issue

3

1 reference

29 May 2018

page(s)

157-165

1 reference

29 May 2018

UbcH10 is overexpressed in malignant breast carcinomas

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

Management of a solitary thyroid nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

BRAF mutation in thyroid cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Genetic Classification of Benign and Malignant Thyroid Follicular Neoplasia Based on a Three-Gene Combination

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Diagnostic and prognostic value of cell-cycle regulatory genes in malignant thyroid neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

The heart of the cycle

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

The processivity of multiubiquitination by the APC determines the order of substrate degradation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

UbcH10 expression may be a useful tool in the prognosis of ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

UbcH10 expression in human lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Utility of cell blocks in the diagnosis of thyroid aspirates

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Ki67 staining pattern as a diagnostic tool in the evaluation of lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Thyroid fine-needle aspiration samples inadequate for reverse transcriptase-polymerase chain reaction analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Expression of ubiquitin-conjugating enzyme E2C/UbcH10 in astrocytic tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Combination of multiple mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of Taiwanese patients with breast cancer by membrane array.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20046

7 January 2021

Identifiers

DOI

10.1002/CNCY.20046

1 reference

29 May 2018

PubMed ID

20544706

1 reference

29 May 2018